Anemia due to Coadministration of Renin-Angiotensin-System Inhibitors and PPARγ Agonists in Uncomplicated Diabetic Patients

Experimental and Clinical Endocrinology & Diabetes, 04/12/2012

Coadministration of RAS inhibitors and PPAR–γ agonists should be considered in the differential diagnosis of hematocrit lowering and anemia in uncomplicated type 2 diabetic patients with normal serum creatinine.

Print Article Summary Cat 2 CME Report